Are you familiar with FLUORESCENCE ENHANCED THERAGNOSIS?

Yes, I use computational methods for determining dose distributions and DNA damage yields when Auger and alpha emitters are used to irradiate biological tissues.  This methodology serves as a first stage for evaluating isotopes with potential for being used in targeted radionuclide therapy (theranostics).

Sorry, no.

Best

Fluorescence-enhanced Theranostics (FET) is an emerging field of research that combines fluorescence imaging and targeted therapy to diagnose and treat diseases simultaneously. FET utilizes the unique properties of fluorescent probes to provide real-time imaging of disease-specific biomarkers and deliver therapeutic agents to the targeted tissues or cells.
FET has several advantages over traditional diagnostic and therapeutic approaches. It enables real-time imaging of disease progression and treatment response, which allows for personalized treatment plans. FET also allows for the precise targeting of therapeutic agents to diseased tissues, reducing off-target effects and minimizing side effects. In addition, FET can be used to monitor the delivery and distribution of therapeutic agents within the body.